1N
1N1.F Nanalysis Scientific Corp
- Market cap
- EUR 8.98M
- P/E
- -
- P/B
- 1.21x
- ROE
- -31.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 1N1.F undervalued?
Graham numberThe Graham number of Nanalysis Scientific Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Nanalysis Scientific Corp fundamental analysis
No fundamental analysis for Nanalysis Scientific Corp yet.
Nanalysis Scientific Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Nanalysis Scientific Corp
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; a 60-NMR platform; 100-NMR platform; 60-TEACH; QUAD NMR Console; and the Cameleon 4 console, a compact alte…
Full company profileNanalysis Scientific Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Nanalysis Scientific Corp annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | 8.38M | 8.36M | 7.87M | 16.0M | 24.8M | 28.5M | 45.5M | 40.1M | 40.8M |
| Gross Profit | - | - | 5.40M | 6.06M | 5.17M | 10.2M | 10.5M | 3.97M | 12.7M | 9.96M | 9.87M |
| Operating Income | - | - | 288K | 66.0K | -3.74M | -1.19M | -9.91M | -13.5M | -3.45M | -3.77M | -2.33M |
| EBITDA | - | - | 660K | 911K | -1.97M | 1.38M | -5.26M | -11.8M | -7.66M | -845K | 1.20M |
| Net Income | - | - | 74.0K | -1.66M | -3.68M | -1.77M | -9.92M | -16.8M | -13.6M | -5.66M | -3.89M |
| EPS | - | - | 0.00 | -0.03 | -0.06 | -0.02 | -0.10 | -0.16 | -0.12 | -0.05 | -0.03 |
| Balance Sheet | |||||||||||
| Total Assets | - | - | 10.9M | 18.3M | 24.0M | 37.8M | 69.9M | 53.8M | 42.4M | 38.4M | 33.6M |
| Total Liabilities | - | - | 2.56M | 3.19M | 9.65M | 13.8M | 22.3M | 30.3M | 26.8M | 25.0M | 21.3M |
| Shareholders' Equity | - | - | 8.39M | 15.1M | 14.3M | 24.0M | 35.1M | 23.5M | 15.5M | 13.4M | 12.3M |
| Cash & Short-term Investments | - | - | 779K | 6.62M | 3.16M | 10.4M | 3.53M | 759K | 1.38M | 545K | 540K |
| Cash Flow | |||||||||||
| Operating Cash Flow | 594K | 1.40M | -171K | 781K | -623K | -1.20M | -8.36M | -11.2M | 3.26M | 3.45M | 1.18M |
| Capital Expenditure | 588K | 131K | 804K | 545K | 427K | 595K | 7.20M | 4.59M | 1.86M | 1.88M | 442K |
| Free Cash Flow | - | - | -2.42M | -2.36M | -3.52M | -4.20M | -15.6M | -15.8M | 1.41M | 1.57M | 740K |
| Ratios | |||||||||||
| ROE | - | - | 0.9% | -11.0% | -25.6% | -7.4% | -28.2% | -71.5% | -87.6% | -42.2% | -31.6% |
| ROA | - | - | 0.7% | -9.1% | -15.3% | -4.7% | -14.2% | -31.2% | -32.1% | -14.7% | -11.6% |
| Net Profit Margin | - | - | 0.9% | -19.8% | -46.7% | -11.0% | -39.9% | -59.0% | -29.9% | -14.1% | -9.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Nanalysis Scientific Corp dividends
Nanalysis Scientific Corp has not paid dividends in the last 9 fiscal years.
Who owns Nanalysis Scientific Corp
- Insiders 3.48%
- Institutions 7.03%
- Public & others 89.48%
- Shares outstanding 139M
- Free float 133M
Nanalysis Scientific Corp company profile
- Company name
- Nanalysis Scientific Corp
- Ticker
- 1N1.F
- ISIN
- CA63000Y1034
- Exchange
- Frankfurt Exchange
- Sector
- Technology
- Industry
- Electronic Equipment, Instruments & Components
- Fiscal year end
- December
- Address
- Bay 1, 4600 5th Street NE, Calgary, AB, Canada, T2E 7C3
- Phone
- 403 769 9499
- Website
- nanalysis.com
About Nanalysis Scientific Corp
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; a 60-NMR platform; 100-NMR platform; 60-TEACH; QUAD NMR Console; and the Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, a user interface for data acquisition and processing of benchtop NMR products; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security services, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, education, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. Nanalysis Scientific Corp. is headquartered in Calgary, Canada.
Nanalysis Scientific Corp management
3- Mr. Sean Krakiwsky M.Sc.Founder, CEO, President & Director · born 1970
- Mr. Julien MuellerChief Technology Officer
- Mr. Marc TomlinsonExecutive Vice President of Services